Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert W van Dijk

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of the American Heart Association|December 3, 2025
Prevalence and Factors Associated With Atrial Fibrillation Among Young Patients With Ischemic StrokeEvi J van Kempen, Mijntje M I Schellekens, Jamie I Verhoeven, et al.
JAMA Neurology|April 14, 2025
Risk of Poststroke Epilepsy Among Young Adults With Ischemic Stroke or Intracerebral HemorrhageEsmée Verburgt, Lina Fellah, Merel S Ekker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 14, 2023
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen, et al.
Neuroimage. Clinical|January 7, 2026
Lesion locations are associated with cognitive impairment after ischemic stroke in young adultsMijntje M I Schellekens, Hao Li, Maartje Wijnands, et al.
JAMA Network Open|February 20, 2024
Short-Term and Long-Term Risk of Recurrent Vascular Event by Cause After Ischemic Stroke in Young AdultsEsmée Verburgt, Nina A Hilkens, Merel S Ekker, et al.
The Lancet. Neurology|September 4, 2022
Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trialSophie A van den Berg, Simone M Uniken Venema, Hendrik Reinink, et al.
The Lancet. Neurology|March 20, 2021
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trialChrista Walgaard, Bart C Jacobs, Hester F Lingsma, et al.
Neurology|December 23, 2021
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome ScoreAlex Y Doets, Hester F Lingsma, Christa Walgaard, et al.
Neurology|April 19, 2023
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré SyndromeHelle Al-Hakem, Alex Y Doets, Amro Maher Stino, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of the American Heart Association|December 3, 2025
Prevalence and Factors Associated With Atrial Fibrillation Among Young Patients With Ischemic StrokeEvi J van Kempen, Mijntje M I Schellekens, Jamie I Verhoeven, et al.
JAMA Neurology|April 14, 2025
Risk of Poststroke Epilepsy Among Young Adults With Ischemic Stroke or Intracerebral HemorrhageEsmée Verburgt, Lina Fellah, Merel S Ekker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 14, 2023
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen, et al.
Neuroimage. Clinical|January 7, 2026
Lesion locations are associated with cognitive impairment after ischemic stroke in young adultsMijntje M I Schellekens, Hao Li, Maartje Wijnands, et al.
JAMA Network Open|February 20, 2024
Short-Term and Long-Term Risk of Recurrent Vascular Event by Cause After Ischemic Stroke in Young AdultsEsmée Verburgt, Nina A Hilkens, Merel S Ekker, et al.
The Lancet. Neurology|September 4, 2022
Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trialSophie A van den Berg, Simone M Uniken Venema, Hendrik Reinink, et al.
The Lancet. Neurology|March 20, 2021
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trialChrista Walgaard, Bart C Jacobs, Hester F Lingsma, et al.
Neurology|December 23, 2021
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome ScoreAlex Y Doets, Hester F Lingsma, Christa Walgaard, et al.
Neurology|April 19, 2023
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré SyndromeHelle Al-Hakem, Alex Y Doets, Amro Maher Stino, et al.
Pageof 3